Silence Therapeutics plc Share Price
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.45 USD | -3.21% |
|
+4.85% | +88.32% |
| 07-22 | European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading | MT |
| 07-10 | European Equities Traded in the US as American Depositary Receipts Decline Friday | MT |
| Market Cap | 418M 556M 489M 454M 783M 53.82B 797M 5.43B 2.12B 26.25B 2.09B 2.04B 91.08B | P/E 2026 * |
-19.8x | P/E 2027 * | -17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 272M 362M 318M 295M 510M 35.02B 519M 3.53B 1.38B 17.08B 1.36B 1.33B 59.26B | EV / Sales 2026 * |
109x | EV / Sales 2027 * | 49.1x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -3.21% | ||
| 1 week | +4.85% | ||
| Current month | +4.28% | ||
| 1 month | +57.50% | ||
| 3 months | +46.05% | ||
| 6 months | +101.94% | ||
| Current year | +88.32% |
| 1 week | 10.16 |  | 11.9 |
| 1 month | 7.43 | | 11.9 |
| Current year | 4.19 | | 11.9 |
| 1 year | 4.19 | | 11.9 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 30/11/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 31/01/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 20/06/2018 |
Iain Ross
CHM | Chairman | 72 | 31/12/2003 |
Tim McInerney
BRD | Director/Board Member | 65 | 04/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Sell | 865,112 | 0.6105% | |||
| 02/01/26 | Free | Director | 90,000 | 0.0635% | ||
| 02/01/26 | Free | Chief Technology Officer | 300,000 | 0.2117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.21% | +4.85% | +86.18% | +116.45% | 559M | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +5.34% | +402.93% | +627.64% | 38.91B | |
| +2.14% | +2.95% | +10.83% | +67.37% | 35.57B | |
| +4.43% | -1.51% | +6.73% | -9.13% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -2.75% | - | - | 16.61B | |
| +14.71% | +12.62% | +38.50% | +145.33% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | +0.19% | +1.45% | -29.80% | 12.81B | |
| Average | +2.01% | -0.59% | +60.96% | +107.47% | 23.92B | |
| Weighted average by Cap. | +2.58% | -2.43% | +75.86% | +133.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.32M 2.92M 2.71M 4.68M 322M 4.77M 32.46M 12.66M 157M 12.47M 12.2M 544M | 3.44M 4.58M 4.03M 3.74M 6.46M 444M 6.57M 44.76M 17.46M 216M 17.2M 16.83M 751M |
| Net income | -50.3M -66.93M -58.87M -54.69M -94.32M -6.48B -96.01M -654M -255M -3.16B -251M -246M -10.97B | -84.54M -113M -98.95M -91.92M -159M -10.9B -161M -1.1B -429M -5.31B -422M -413M -18.44B |
| Net Debt | -146M -194M -171M -159M -274M -18.8B -279M -1.9B -740M -9.17B -729M -713M -31.82B | -249M -331M -291M -270M -467M -32.06B -475M -3.23B -1.26B -15.64B -1.24B -1.22B -54.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | US$11.45 | -3.21% | 479,696 |
| 22/07/26 | US$11.83 | +9.03% | 847,510 |
| 21/07/26 | US$10.85 | +3.43% | 162,992 |
| 20/07/26 | US$10.49 | -0.10% | 360,152 |
| 17/07/26 | US$10.50 | -3.85% | 277,230 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
